TF and neoplasm: Consistent with previous studies in which TF’s procoagulant activity on A549 cells was blocked with an antibody [5,21], we used a short hairpin RNA (shRNA) to genetically interfere with the TF expression of A549 cells to validate the connection between TF and tumor cell procoagulant activity.